These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37572228)

  • 1. Lewy Body Dementia: An Overview of Promising Therapeutics.
    Skylar-Scott IA; Sha SJ
    Curr Neurol Neurosci Rep; 2023 Oct; 23(10):581-592. PubMed ID: 37572228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
    Rolinski M; Fox C; Maidment I; McShane R
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Therapies and Drug Development Pipeline in Lewy Body Dementia: An Update.
    MacDonald S; Shah AS; Tousi B
    Drugs Aging; 2022 Jul; 39(7):505-522. PubMed ID: 35619045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
    Jellinger KA; Korczyn AD
    BMC Med; 2018 Mar; 16(1):34. PubMed ID: 29510692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.
    Jellinger KA
    J Neural Transm (Vienna); 2018 Apr; 125(4):615-650. PubMed ID: 29222591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging drugs for dementia with Lewy Bodies: a review of Phase II & III trials.
    Tolea MI; Ezzeddine R; Camacho S; Galvin JE
    Expert Opin Emerg Drugs; 2023 Dec; 28(3):167-180. PubMed ID: 37531299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological Management of Dementia with Lewy Bodies.
    Hershey LA; Coleman-Jackson R
    Drugs Aging; 2019 Apr; 36(4):309-319. PubMed ID: 30680679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic trials in dementia with Lewy bodies: a systematic review of the literature].
    Sacrez M; Lamothe M; Rauch L; Botzung A; Blanc F
    Geriatr Psychol Neuropsychiatr Vieil; 2021 Sep; 19(3):289-304. PubMed ID: 34609295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lewy Body Dementias: Dementia With Lewy Bodies and Parkinson Disease Dementia.
    Gomperts SN
    Continuum (Minneap Minn); 2016 Apr; 22(2 Dementia):435-63. PubMed ID: 27042903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dementia with Lewy bodies: emerging drug targets and therapeutics.
    Pope ED; Cordes L; Shi J; Mari Z; Decourt B; Sabbagh MN
    Expert Opin Investig Drugs; 2021 Jun; 30(6):603-609. PubMed ID: 33899637
    [No Abstract]   [Full Text] [Related]  

  • 11. A soluble tau fragment generated by caspase-2 is associated with dementia in Lewy body disease.
    Smith BR; Nelson KM; Kemper LJ; Leinonen-Wright K; Petersen A; Keene CD; Ashe KH
    Acta Neuropathol Commun; 2019 Jul; 7(1):124. PubMed ID: 31362787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lewy Body Dementias: A Coin with Two Sides?
    Milán-Tomás Á; Fernández-Matarrubia M; Rodríguez-Oroz MC
    Behav Sci (Basel); 2021 Jun; 11(7):. PubMed ID: 34206456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of psychosis in Parkinson's disease and dementia with Lewy Bodies: A review.
    Kyle K; Bronstein JM
    Parkinsonism Relat Disord; 2020 Jun; 75():55-62. PubMed ID: 32480308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathological and clinical comparison of Parkinson’s disease dementia and dementia with Lewy bodies].
    Bencs V; Bencze J; Módis VL; Simon V; Kálmán J; Hortobágyi T
    Orv Hetil; 2020 May; 161(18):727-737. PubMed ID: 32338488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and economic burden of Lewy body dementia in the United States.
    Desai U; Chandler J; Kirson N; Georgieva M; Cheung HC; Westermeyer B; Lane H; Biglan K
    Curr Med Res Opin; 2022 Jul; 38(7):1177-1188. PubMed ID: 35442134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prodromal dementia with Lewy bodies.
    Fujishiro H; Nakamura S; Sato K; Iseki E
    Geriatr Gerontol Int; 2015 Jul; 15(7):817-26. PubMed ID: 25690399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Therapeutic Strategies for Lewy Body Dementias.
    Velayudhan L; Ffytche D; Ballard C; Aarsland D
    Curr Neurol Neurosci Rep; 2017 Sep; 17(9):68. PubMed ID: 28741230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials.
    Goldman JG; Forsberg LK; Boeve BF; Armstrong MJ; Irwin DJ; Ferman TJ; Galasko D; Galvin JE; Kaufer D; Leverenz J; Lippa CF; Marder K; Abler V; Biglan K; Irizarry M; Keller B; Munsie L; Nakagawa M; Taylor A; Graham T
    Alzheimers Res Ther; 2020 Oct; 12(1):137. PubMed ID: 33121510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral symptomatology and psychopharmacology of Lewy body dementia.
    Tampi RR; Young JJ; Tampi D
    Handb Clin Neurol; 2019; 165():59-70. PubMed ID: 31727230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and clinical associations of tau in Lewy body dementias: A systematic review and meta-analysis.
    Chin KS; Yassi N; Churilov L; Masters CL; Watson R
    Parkinsonism Relat Disord; 2020 Nov; 80():184-193. PubMed ID: 33260030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.